文献速递妇产影像技术与安全US

解码22q11.2:丹麦全国队列的产前特征分析与早孕期风险评估

Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

这项丹麦全国注册队列研究分析了143例胎儿22q11.2缺失或重复妊娠的早孕期筛查标志物分布,发现经典重复的筛查标志物模式类似常见三体,而经典缺失伴PAPP-A升高,限制了现有联合筛查的早期检出;靶向风险算法可使经典缺失产前检出率增加一倍以上,但假阳性率大幅升高。

要点

  • 经典22q11.2重复的早孕期筛查标志物模式类似常见三体,PAPP-A MoM降低。
  • 经典22q11.2缺失伴PAPP-A MoM升高,可能限制现行联合筛查风险算法的早期检出。
  • 靶向风险算法使经典缺失产前检出率增加一倍以上,但假阳性率大幅升高。

核心结论

  • 经典22q11.2重复的早孕期联合筛查标志物分布类似常见三体(PAPP-A降低),而经典缺失伴PAPP-A升高,可能限制现行联合筛查算法的早期检出;基于NT、PAPP-A和β-hCG的靶向风险算法改善经典缺失早期检出的空间有限。

研究设计与样本

  • 丹麦全国注册队列研究,纳入2008年1月至2018年12月预产期期间接受产前筛查的妊娠,从丹麦细胞遗传学中央注册处检索产前或产后或流产/终止妊娠后诊断的胎儿22q11.2缺失或重复(hg19 chr22:18.9mio-25.0mio)病例,并与丹麦胎儿医学数据库妊娠数据链接。

关键影像表现/征象

  • 共纳入143例胎儿22q11.2异常妊娠,其中缺失97例(经典54例)、重复46例(经典32例);经典缺失、任何缺失、任何重复的NT均值分别为1.89 mm、1.78 mm、1.86 mm,均高于参考组均值1.65 mm。

诊断标准与关键数值

  • β-hCG MoM在经典缺失和任何缺失中均值分别为0.77和0.71,低于参考组均值1.02;PAPP-A MoM在经典重复和任何重复中均值分别为0.57和0.63,低于参考组均值1.01,在经典缺失和任何缺失中均值分别为1.34和1.16,高于参考组。

临床应用与阅片要点

  • 联合筛查阳性率在经典缺失为13.7%、任何缺失为12.5%、经典重复为46.9%、任何重复为37.8%,均高于参考组4.5%;靶向风险算法使经典22q11.2缺失的产前检出率增加一倍以上,但假阳性率大幅升高。

局限性

  • 基于NT、PAPP-A和β-hCG的靶向风险算法改善经典22q11.2缺失早期检出的空间有限。
  • 靶向风险算法使经典22q11.2缺失产前检出率增加一倍以上的同时,假阳性率大幅升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To examine the distribution of nuchal translucency thickness (NT), free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) in pregnancies with a fetal 22q11.2 aberration. Furthermore, the performance of combined first-trimester screening (cFTS) and a new risk algorithm targeting 22q11.2 deletions in detecting affected pregnancies was evaluated. Finally, prenatal malformations and pregnancy outcome were assessed.

METHODS: This was a nationwide registry-based cohort study of all pregnancies that underwent prenatal screening with a due date between January 2008 and December 2018 in Denmark. All cases with a fetal 22q11.2 deletion or duplication (hg19 chr22:18.9mio-25.0mio) diagnosed pre- or postnatally or following pregnancy loss or termination of pregnancy were retrieved from the Danish Cytogenetic Central Register and linked with pregnancy data from the Danish Fetal Medicine Database. Fetal and maternal characteristics, including cFTS results and pregnancy outcome, of pregnancies with any 22q11.2 deletion or duplication (LCR22-A to -H) and pregnancies with a classic deletion or duplication (LCR22-A to -D) diagnosed by chromosomal microarray were compared with those of a chromosomally normal reference group. A risk algorithm was developed for assessing patient-specific risks for classic 22q11.2 deletions based on NT, PAPP-A and β-hCG. Detection rates and false-positive rates at different risk cut-offs were calculated.

RESULTS: We included data on 143 pregnancies with a fetal 22q11.2 aberration, of which 97 were deletions (54 classic) and 46 were duplications (32 classic). NT was significantly increased in fetuses with a classic deletion (mean, 1.89 mm), those with any deletion (mean, 1.78 mm) and those with any duplication (mean, 1.86 mm) compared to the reference group (mean, 1.65 mm). β-hCG multiples of the median (MoM) was decreased in all 22q11.2 subgroups compared with the reference group (mean, 1.02) and reached significance in pregnancies with a classic deletion and those with any deletion (mean, 0.77 and 0.71, respectively). PAPP-A MoM was significantly decreased in pregnancies with a classic duplication and those with any duplication (mean, 0.57 and 0.63, respectively), and was significantly increased in pregnancies with a classic deletion and those with any deletion (mean, 1.34 and 1.16, respectively), compared to reference pregnancies (mean, 1.01). The screen-positive rate by cFTS was significantly increased in pregnancies with a classic deletion (13.7%), any deletion (12.5%), a classic duplication (46.9%) or any duplication (37.8%) compared to the reference group (4.5%). A risk algorithm targeting classic 22q11.2 deletions more than doubled the prenatal detection rate of classic 22q11.2 deletions, but with a substantial increase in the false-positive rate. Structural malformations were detected in 41%, 35%, 17% and 25% of the pregnancies with a classic deletion, any deletion, classic duplication or any duplication, respectively. Pregnancy loss occurred in 40% of pregnancies with a classic deletion and 5% of those with a classic duplication diagnosed prenatally or following pregnancy loss.

CONCLUSIONS: The distribution of cFTS markers in pregnancies with a classic 22q11.2 duplication resembles that of the common trisomies, with decreased levels of PAPP-A. However, classic 22q11.2 deletions are associated with increased levels of PAPP-A, which likely limits early prenatal detection using the current cFTS risk algorithm. The scope for improving early detection of classic 22q11.2 deletions using targeted risk algorithms based on NT, PAPP-A and β-hCG is limited. This demonstrates the capability, but also the limitations, of cFTS markers in detecting atypical chromosomal anomalies, which is important knowledge when designing new prenatal screening programs. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gadsbøll K, Vogel I, Pedersen LH, et al. Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort. Ultrasound Obstet Gynecol. 2024. PMID: 37643358. doi:10.1002/uog.27466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。